Influenza :: Roche files supplemental new drug application for Tamiflu

Roche has filed a supplemental new drug application (sNDA) with the U.S. Food and Drug Administration (FDA) to market Tamiflu (oseltamivir phosphate) capsules in pediatric doses of 30 mg and 45 mg. Tamiflu, which is indicated for the prevention and treatment of influenza types A and B in patients one year and older, is currently available in a 75 mg capsule for adults as well as liquid suspension formulation for children.

Mental Health :: Indian National Mental Health Act need to reviewed

Speaking on the occasion of inaugural programme of International Women’s Day and the seminar on “Mentally Ill Women – is Destitution the only Answer?” in New Delhi, the Indian Minister for Health & Family Welfare, Dr. Anbumani Ramadoss said that mentally ill women face formidable socio-economic problems such as neglect by family and society, dislocation, abandonment and are vulnerable as easy targets of sexual abuse.

Peanut Butter :: FDA updates Salmonella linked Peanut Butter Recall back to 2004

As a follow-up to the recent Salmonella outbreak linked to peanut butter, the U.S. Food and Drug Administration (FDA) is informing consumers that ConAgra has extended their recall of all Peter Pan peanut butter, and all Great Value peanut butter beginning with product code 2111, including peanut butter toppings, back to October 2004.

Botulism :: Flora Foods recalls Cerignola Olives because of possible health risk

Flora Foods of Pompano Beach, Florida, is recalling its 25oz jars of “Cerignola Olives” (UPC 0-20038-00693-5) because they have the potential to be contaminated with Clostridium botulinum, a bacterium which can cause life-threatening illness or death. Consumers are warned not to use the product even if it does not look or smell spoiled.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack